News
Latest Posts
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial for Major Depressive Disorder
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase I/IIa clinical trial
Aducanumab for the treatment of Alzheimer’s
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the new drug Aducanumab for the treatment of Alzheimer’s,
What are Opioids?
Opioids are medications prescribed by doctors to treat persistent or severe pain. They can either be sourced synthetically or derived
What is OCD?
Obsessive-Compulsive Disorder (commonly referred to as OCD), is a mental health condition that affects around three quarters of a million
Illuminating Parkinson’s Awareness
In honour of this year’s Parkinson’s Awareness Week, the Ashton Memorial in Lancaster, UK has been illuminated blue, the colour
MHRA approve the launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of opioid use disorder
MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.
Dr Peter Dewland, Senior Director of Early Phase Research has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
Interview – Living with Ulcerative Colitis
When did you get diagnosed with Ulcerative Colitis? I was diagnosed in March 2017; I had been suffering with blood
Brian and Sue – Our MAC Clinical Research Experience
Brian, aged 83 a retired English electric engineer, married his wife Sue in 1962; they have been happily married for
Featured Posts
Categories
Follow Us
Follow MAC Clinical Research on social media to keep up to date with our latest news and clinical trials.
